{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:44:38Z","timestamp":1791834278989,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","psychosomaticsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.psym.2017.04.001","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T16:53:51Z","timestamp":1491411231000},"page":"343-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Cystic Fibrosis Transmembrane Regulator Modulators: Implications for the Management of Depression and Anxiety in Cystic Fibrosis"],"prefix":"10.1016","volume":"58","author":[{"given":"Jaideep S.","family":"Talwalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Koff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hochang B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente J.","family":"Britto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle M.","family":"Mulenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Georgiopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psym.2017.04.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2015.10.002","article-title":"Epidemiology of cystic fibrosis","volume":"37","author":"Spoonhower","year":"2016","journal-title":"Clin Chest Med"},{"issue":"8","key":"10.1016\/j.psym.2017.04.001_bib2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.psym.2017.04.001_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jcf.2010.04.002","article-title":"Year-to-year changes in lung function in individuals with cystic fibrosis","volume":"9","author":"Liou","year":"2010","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.psym.2017.04.001_bib5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0029-1238910","article-title":"Diabetes mellitus and bone disease in cystic fibrosis","volume":"30","author":"Curran","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.psym.2017.04.001_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s13300-016-0205-8","article-title":"A practical approach to glucose abnormalities in cystic fibrosis","volume":"7","author":"Jones","year":"2016","journal-title":"Diabetes Ther"},{"issue":"4","key":"10.1016\/j.psym.2017.04.001_bib7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jcf.2016.01.002","article-title":"Colonoscopic screening shows increased early incidence and progression of adenomas in cystic fibrosis","volume":"15","author":"Niccum","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.psym.2017.04.001_bib8","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.psym.2017.04.001_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccm.2015.11.002","article-title":"Genetics of cystic fibrosis, clinical implications","volume":"37","author":"Egan","year":"2016","journal-title":"Clin Chest Med"},{"issue":"7","key":"10.1016\/j.psym.2017.04.001_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 44","key":"10.1016\/j.psym.2017.04.001_bib11","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/ppul.23505","article-title":"Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis","volume":"51","author":"Jordan","year":"2016","journal-title":"Pediatr Pulmonol"},{"issue":"suppl 40","key":"10.1016\/j.psym.2017.04.001_bib12","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/ppul.23244","article-title":"Tackling the increasing complexity of CF care","volume":"50","author":"Sawicki","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.psym.2017.04.001_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ccm.2015.11.009","article-title":"Nutritional issues in cystic fibrosis","volume":"37","author":"Solomon","year":"2016","journal-title":"Clin Chest Med"},{"issue":"5","key":"10.1016\/j.psym.2017.04.001_bib14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"issue":"1","key":"10.1016\/j.psym.2017.04.001_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner","year":"2016","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.psym.2017.04.001_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJMe1504059","article-title":"Another beginning for cystic fibrosis therapy","volume":"373","author":"Davis","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.psym.2017.04.001_bib17","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.psym.2017.04.001_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.psym.2017.04.001_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-genom-090314-050024","article-title":"Cystic fibrosis and its management through established and emerging therapies","volume":"17","author":"Spielberg","year":"2016","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.psym.2017.04.001_bib20","unstructured":"Cystic Fibrosis Foundation: Drug Development Pipeline [Internet]. Bethesda: Cystic Fibrosis Foundation; 2017 [cited February 27, 2017]. https:\/\/www.cff.org\/Trials\/Pipeline"},{"issue":"12","key":"10.1016\/j.psym.2017.04.001_bib21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","article-title":"Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries","volume":"69","author":"Quittner","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.psym.2017.04.001_bib22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/1060028013514846","article-title":"Prevalence of depression andantidepressant therapy use in a pediatric cystic fibrosis population","volume":"48","author":"Ploessl","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.psym.2017.04.001_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1378\/chest.06-2474","article-title":"The association between depression, lung function, and health related quality of life among adults with cystic fibrosis","volume":"132","author":"Riekert","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.psym.2017.04.001_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1471-2466-14-205","article-title":"Symptoms of depression impact the course of lung function in adolescents and adults with\u00a0cystic fibrosis","volume":"14","author":"Fidika","year":"2014","journal-title":"BMC Pulm Med"},{"issue":"12","key":"10.1016\/j.psym.2017.04.001_bib25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/ppul.22990","article-title":"Depression, illness severity, and healthcare utilization in cystic fibrosis","volume":"49","author":"Snell","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.psym.2017.04.001_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1037\/hea0000136","article-title":"Medication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis","volume":"34","author":"Hilliard","year":"2015","journal-title":"Health Psychol"},{"key":"10.1016\/j.psym.2017.04.001_bib27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ppul.21238","article-title":"Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance","volume":"45","author":"Smith","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.psym.2017.04.001_bib28","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1186\/s40064-016-2862-5","article-title":"Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis","volume":"5","author":"Knudsen","year":"2016","journal-title":"Springerplus"},{"issue":"suppl 44","key":"10.1016\/j.psym.2017.04.001_bib29","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1002\/ppul.23522","article-title":"Maintaining mental health and function for the long run in cystic fibrosis","volume":"51","author":"Smith","year":"2016","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.psym.2017.04.001_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jcf.2014.12.015","article-title":"Cystic Fibrosis Foundation and European Cystic Fibrosis Society survey of cystic fibrosis mental health care delivery","volume":"14","author":"Abbott","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.psym.2017.04.001_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2011-200393","article-title":"Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation","volume":"67","author":"Clancy","year":"2012","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.psym.2017.04.001_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S2213-2600(14)70132-8","article-title":"A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial","volume":"2","author":"Boyle","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.psym.2017.04.001_bib33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.psym.2017.04.001_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.psym.2017.04.001_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.genhosppsych.2016.09.007","article-title":"Examining the relationship between physical illness and depression: Is there a difference between inflammatory and non inflammatory diseases? A cohort study","volume":"43","author":"Caneo","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"issue":"11","key":"10.1016\/j.psym.2017.04.001_bib36","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1176\/appi.ajp.2015.15020152","article-title":"Inflammation: depression fans the flames and feasts on the heat","volume":"172","author":"Kiecolt-Glaser","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psym.2017.04.001_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/jocn.13724","article-title":"Life after a lung transplant: a balance of joy and challenges","author":"Graarup","year":"2017","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.psym.2017.04.001_bib38","unstructured":"Desch J: Wellness: Survivor Guilt [Internet]. CF Roundtable; 2016 [cited February 27, 2017]. Available from: http:\/\/www.cfroundtable.com\/online-newsletters\/summer-2016-newsletter\/#jump4"},{"key":"10.1016\/j.psym.2017.04.001_bib39","unstructured":"Russell K: Speeding Past 50: Wahoo, Life Is Good [Internet]. CF Roundtable; 2016 [cited February 27, 2017]. Available from: http:\/\/www.cfroundtable.com\/online-newsletters\/summer-2016-newsletter\/#jump4"},{"key":"10.1016\/j.psym.2017.04.001_bib41","unstructured":"Friedman D, Georgiopoulos A: CF\u2010specific cognitive behavioral therapy: development of an intervention manual in partnership with adult patients with CF and CF healthcare providers. Presented at Vertex 2nd Annual CF Circle of Care Colloquium, Orlando (United States); October 2016."},{"issue":"12","key":"10.1016\/j.psym.2017.04.001_bib42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1369\/jhc.2009.953455","article-title":"Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the human brain","volume":"57","author":"Guo","year":"2009","journal-title":"J Histochem Cytochem"},{"issue":"suppl 45","key":"10.1016\/j.psym.2017.04.001_bib43","first-page":"S471","article-title":"Cognitive function in adults with cystic fibrosis: the effects of CF-related diabetes and transplantation","volume":"51","author":"Chadwick","year":"2016","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.psym.2017.04.001_bib44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/cpt.548","article-title":"Can cystic fibrosis patients finally catch a breath with lumacaftor\/ivacaftor?","volume":"101","author":"Schneider","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.psym.2017.04.001_bib45","first-page":"77","article-title":"Paroxetine \u2014the antidepressant from hell? Probably not, but caution required","volume":"46","author":"Nevels","year":"2016","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.psym.2017.04.001_bib46","unstructured":"Indiana University School of Medicine: Flockhart Table: P450 Drug Interaction Table [Internet]. Indianapolis: Indiana University; 2016 [cited 2017 Feb 27]. Available from: http:\/\/medicine.iupui.edu\/clinpharm\/ddis\/main-table"},{"key":"10.1016\/j.psym.2017.04.001_bib47","first-page":"40","article-title":"Get to know an enzyme: CYP3A4","volume":"9","author":"Horn","year":"2008","journal-title":"Pharm Times"},{"key":"10.1016\/j.psym.2017.04.001_bib48","unstructured":"Vertex Pharmaceuticals Incorporated: Highlights of Prescribing Information: Orkambi [Internet]. Boston: Vertex Pharmaceuticals Incorporated; September 2016 [cited February 27, 2017]. Available from: http:\/\/pi.vrtx.com\/files\/uspi_lumacaftor_ivacaftor.pdf"},{"issue":"3","key":"10.1016\/j.psym.2017.04.001_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrgastro.2015.226","article-title":"Cystic fibrosis from the gastroenterologist\u02bcs perspective","volume":"13","author":"Ooi","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.psym.2017.04.001_bib50","unstructured":"Cystic Fibrosis Foundation: Career Development Awards [Internet]. Bethesda: Cystic Fibrosis Foundation; 2017 [cited February 27, 2017]. Available from: https:\/\/www.cff.org\/Our-Research\/For-Researchers\/Career-Development-Awards\/"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318217301093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318217301093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T19:25:00Z","timestamp":1535916300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318217301093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0033318217301093"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2017.04.001","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic Fibrosis Transmembrane Regulator Modulators: Implications for the Management of Depression and Anxiety in Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Psychosomatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psym.2017.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}